A detailed history of Summit Trail Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 35,131 shares of JNJ stock, worth $5.13 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
35,131
Previous 18,418 90.74%
Holding current value
$5.13 Million
Previous $2.89 Million 92.55%
% of portfolio
0.15%
Previous 0.1%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$155.22 - $162.74 $2.59 Million - $2.72 Million
16,713 Added 90.74%
35,131 $5.56 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $493,729 - $538,762
-3,391 Reduced 15.55%
18,418 $2.89 Million
Q3 2023

Oct 30, 2023

BUY
$155.75 - $174.48 $265,865 - $297,837
1,707 Added 8.49%
21,809 $3.4 Million
Q2 2023

Jul 25, 2023

BUY
$154.35 - $166.11 $1.21 Million - $1.3 Million
7,836 Added 63.88%
20,102 $3.33 Million
Q1 2023

May 04, 2023

BUY
$151.05 - $180.26 $87,306 - $104,190
578 Added 4.95%
12,266 $1.9 Million
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $94,838 - $106,435
592 Added 5.34%
11,688 $2.06 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $112,769 - $125,484
-699 Reduced 5.93%
11,096 $1.81 Million
Q2 2022

Aug 09, 2022

BUY
$168.19 - $186.01 $976,847 - $1.08 Million
5,808 Added 97.01%
11,795 $2.09 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $237,368 - $269,564
1,501 Added 33.46%
5,987 $1.06 Million
Q4 2021

Feb 11, 2022

BUY
$155.93 - $173.01 $19,335 - $21,453
124 Added 2.84%
4,486 $767,000
Q3 2021

Nov 16, 2021

BUY
$161.5 - $179.47 $231,268 - $257,001
1,432 Added 48.87%
4,362 $704,000
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $128,700 - $138,053
-807 Reduced 21.59%
2,930 $483,000
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $52,656 - $58,645
-344 Reduced 8.43%
3,737 $614,000
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $290,124 - $333,016
-2,116 Reduced 34.15%
4,081 $642,000
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $869,934 - $953,284
6,197 New
6,197 $919,000
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $491,049 - $538,097
-3,498 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $134,348 - $162,196
1,043 Added 42.48%
3,498 $492,000
Q1 2020

May 15, 2020

BUY
$111.14 - $153.99 $272,848 - $378,045
2,455 New
2,455 $322,000
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $2.02 Million - $2.23 Million
-16,927 Closed
0 $0
Q1 2018

May 22, 2018

SELL
$125.1 - $148.14 $219 Million - $259 Million
-1,750,905 Reduced 99.04%
16,927 $1.77 Million
Q1 2018

May 21, 2018

BUY
$125.1 - $148.14 $219 Million - $260 Million
1,752,841 Added 11692.62%
1,767,832 $1.77 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $1.97 Million - $2.15 Million
14,991
14,991 $2.12 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.